Recent advances in our understanding of the pathobiology of non-coding RNA by Zorman, Jernej
AUTHOR
EDUCATION
Recent advances in our 
understanding of the pathobiology 
of non-coding RNA
Summary
The central dogma of molecular biology recognised RNA as a 
mere intermediate between DNA sequence and proteins, the main 
protagonists of cellular functions. The shadow of a wrinkle in this 
concept appeared when the Human Genome Project revealed that 
protein-coding genes only account for 2% of our genome and the 
remaining 98% was originally dismissed as elusive “junk DNA.”
Relevance
Recent advances in next-generation sequencing provided tantalising 
evidence that 70-90% of human genome is actively transcribed(1). 
Numerous studies started discerning the functional importance of 
long and short (>200 and <200 nucleotides, respectively) non-coding 
transcripts far beyond the initial textbook-engraved infrastructural and 
information-transmitting role of rRNA, tRNA and mRNA. 
Take Home Messages
By “rediscovering the junk,” this essay reviews a selection of recent 
disease-associated advances in the field of small non-coding RNAs 
before extending the discussion to long non-coding RNAs and 
finally to the overarching concepts of competing endogenous RNAs 
(ceRNAs) and ‘social’ RNA. 
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RNA interference (RNAi)
RNA interference is a process whereby micro RNA (miRNA) 
and small interfering RNA (siRNA) molecules inhibit target gene 
expression by acting on mRNA. The first miRNA to be identified, 
lin-4, was discovered as a short non-coding RNA required for 
repression of lin-14 gene and subsequent maturation of C. elegans 
larvae. (2) The sequence of lin-4 displayed complementarity to 
the 3’ untranslated region (UTR) of lin-14 mRNA, (2) suggesting 
that lin-4 regulates lin-14 expression through an RNA-RNA 
interaction. The discovery of let-7 miRNA (3) and its conservation 
from worms to humans (4) first underscored the prevalence and 
functional importance of miRNA-dependent gene regulation. 
Although estimated to represent less than one percent of our 
genome, miRNAs have been proposed to regulate as many as 92% 
of human genes. (5)
What is the mechanism of gene regulation by miRNAs? The 
process of miRNA biogenesis typically starts with RNA 
polymerases transcribing miRNA genes into primary miRNAs, 
which fold to form hairpin-loop structures (Figure 1). These are 
recognised and cleaved by the Microprocessor complex to form 
precursor miRNAs (pre-miRNAs). Following nuclear export, 
pre-miRNAs are cleaved by a protein complex involving Dicer 
endonuclease and one of the resulting 21-23bp strands assembles 
with Argonaute proteins into an RNA-induced silencing complex 
(RISC). Using miRNA as a guide, RISC binds to complementary 
miRNA-response elements (MREs) in 3’ untranslated region 
(UTR) of target mRNAs leading to mRNA cleavage or 
translational inhibition. While miRNAs are endogenous, siRNAs 
are exogenous RNA duplexes that enter the cell, are cleaved 
by Dicer and follow the same processing and functional path as 
miRNAs. 
About 20 years since their discovery and landmark observations, 
miRNAs are recognised as regulators of most cellular processes, 
with their derangements reported in a host of human disease.
miRNAs in tumorigenesis
Tumorigenesis is generally associated with gain-of-function 
mutations or amplification of oncogenes and/or loss-of-function 
mutations in tumour suppressor genes (TSG). Oncomirs, 
i.e. miRNAs that promote cancer, typically repress TSGs. 
The polycistronic cluster miR-17-92 is located in a region of 
chromosome 13q and is frequently amplified in tumours. (6) The 
binding of oncprotein MYC to this cluster drives the expression 
of six miRNAs with reported roles in cell proliferation, apoptosis 
and angiogenesis. (7) Overexpression of this cluster in MYC-
driven mouse model of lymphoma accelerated tumorigenesis by 
suppressing apoptosis, (8) identifying miR-17-92 as an oncomir 
normally acting downstream of MYC. 
The first evidence for altered miRNA expression in cancer 
came from genome-wide studies in patients with B-cell chronic 
lymphocytic leukaemia (B-CLL), the most prevalent type of adult 
leukaemia. Using somatic cell hybridisation, 68% of B-CLL 
patients were found to carry a deletion in the gene cluster encoding 
miR-15 and miR-16 miRNAs. (9) Prolonged survival of B cells in 
B-CLL corresponded to increased expression of the anti-apoptotic 
protein Bcl-2 (among other targets), a process successfully reversed 
by forced expression of miR-15 and miR-16 into cultured B cells 
of B-CLL patients. (10) This demonstrated the tumour-suppressing 
function of miR-15 and miR-16, which was confirmed in mouse 
xenograft experiments: human prostatic tumour grafts transfected 
with miR-15 and mir-16 displayed increased regression compared 
to untransfected controls. (11) Hence, miRNAs can function as 
TSGs and their restoration bears therapeutic promise.
Human cancers typically show a global decrease in miRNA 
expression, (12) which could reflect the undifferentiated state of 
tumours or causally contribute to the transformed phenotype. To 
answer this question, Kumar and co-workers generated mouse and 
human lines deficient in miRNA processing proteins Drosha or 
DGCR8 (components of the microprocessor complex) and Dicer1. 
These lines displayed a substantial decrease in steady state miRNA 
levels, increased growth in soft agar cultures and more malignant 
behaviour when injected into nude mice compared to controls, (12) 
demonstrating that miRNA pathways tend to act as an overall brake 
on cancer growth rather than simply reflecting the undifferentiated 
state. Interestingly, overexpression of let-7 miRNA alone reversed 
the in vitro effects of Dicer1 knockdown (12), implying that let-7 
may be the key TSGs among miRNAs. Let-7 miRNAs target 
the KRAS oncogene, (13) whose properties have to date thwarted 
all therapeutic efforts using small molecule inhibitors. Hence, 
overexpression of let-7 miRNA provides an alternative approach to 
target KRAS, which is frequently mutated in human cancer. (14)
miRNAs in immunity
One caveat in therapeutic application of miRNAs is that a 
single miRNA typically induces pleiotropic effects in cell types 
with different transcriptional profiles. While let-7 suppresses 
tumorigenesis in cancer cells, (13) it was demonstrated to play a 
diametrically opposite role in tumour-associated macrophages 
(TAMs). (15) TAMs typically exist as two populations: tumour-
reactive (M1) macrophages attack tumour cells whereas tumour-
tolerant (M2) macrophages supress anti-tumour immunity. Global 
ablation of miRNAs by deletion of Dicer1 in mice resulted in 
polarisation of M2 towards M1 population and boosted anti-
tumour reactivity. (15) This process was rescued by forced 
expression of let-7 miRNA, (15) suggesting that the tumour-
tolerant M2 phenotype is chiefly maintained by let-7 miRNA.
In adaptive immunity, tolerance mechanisms including regulatory 
T (Treg) cells prevent other T cells from reacting against self-
proteins, thereby limiting autoimmune disease. Tregs exist in two 
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populations: natural nTregs differentiate in the thymus whereas 
induced iTregs are induced by IL-2 and TGFβ stimulation of 
naïve CD4 T cells in the periphery. nTregs and iTregs differ 
epigenetically (16) and iTregs were shown to lose Treg markers 
(and immunosuppressive function) and differentiate into exTreg 
cells (16) (Figure 2). The latter recognise self-antigens and 
can, instead of suppressing autoimmunity, actually attack self-
antigens themselves. (17) This raises the question of what causes 
iTregs to become exTregs? Immunosuppressive Treg cells and 
immunoreactive TH17 cells have diametrically opposite functions, 
yet share many differentiation factors. In the presence of IL-1β 
(from activated monocytes) and IL-2, iTregs downregulate the 
canonical Treg transcription factor Foxp3 (i.e. become exTregs) 
and start producing pro-inflammatory IL-17, thus functionally 
resembling TH17 cells. (18) Interestingly, the transition from 
iTreg cells to TH17-like exTreg cells has been shown to involve 
miRNAs. Peripheral CD4 T cells from humans with systemic 
lupus erythematosus and Crohn’s disease as well as autoimmune 
mouse models demonstrated downregulation of miR-125a, which 
stabilises both the commitment and regulatory capacity of Treg 
cells. (19) Mice deficient in miR-125a spontaneously developed 
autoimmune disease, which was successfully reversed using 
synthetic miR-125a analogues. (19) Hence, miR-125a serves as a 
transcriptional regulator of Treg cells whose forced re-expression 
can re-wire aberrant Treg cells back to normal physiological 
function and prevent autoimmunity.
tRNA fragments in transgenerational epigenetic inheritance
Besides the conventional role of tRNAs in translation, striking 
new evidence suggests an active role of tRNA fragments (tRFs) 
in transgenerational inheritance independent of changes in DNA 
sequence. Using in vitro fertilisation, offspring of males consuming 
a low-protein diet exhibited significant hepatic up-regulation 
of squalene epoxidase (involved in cholesterol biosynthesis) 
compared to controls, implying that paternal diet can affect 
offspring metabolism via information located in sperm. (20) Deep 
sequencing of small RNAs in sperm of low-protein diet versus 
control males demonstrated the former to have increased abundance 
of tRFs, whose injection into normal zygotes recapitulated the 
metabolic phenotype of tRF donors. (21) Locked nucleic acid 
(LNA) oligonucleotides blocking tRFs derived from the 5’ end 
of glycine tRNA resulted in dramatic up-regulation of about 70 
genes, (22) demonstrating that tRFs can profoundly influence the 
transcriptional profile of the zygote. Hence, sperm tRFs present a 
paternal epigenetic factor mediating transgenerational inheritance of 
diet-induced metabolic disorders.
Long non-coding RNAs
While short non-coding RNAs mainly affect mRNA stability 
and translation, the functional repertoire of long non-coding (lnc) 
RNAs is considerably more versatile. This includes chromatin 
binding and epigenetic regulation, protein scaffolding and 
“sponging” of miRNAs as discussed below.
Selective targeting of mitochondrial metabolism in melanoma 
through the lncRNA SAMMSON
The survival of several tumours requires oxidative phosphorylation, 
which stimulated the development of metabolism-targeting anti-
cancer agents. Single nucleotide polymorphism (SNP) array data 
revealed that focal amplifications of chromosome 3p characteristic 
of melanoma invariably encompass a newly annotated lncRNA 
gene SAMMSON, which was found to be selectively expressed in 
more than 90% of human primary and metastatic skin melanomas 
as demonstrated by RNA sequencing. (23) Prognosis and clinical 
success of current anti-melanoma therapies is associated with 
mutational status of BRAF, NRAS and TP53 of the tumour while 
chronic treatment with novel BRAF inhibitors, e.g. vemurafenib, 
invariably leads to drug resistance. (24) Promisingly, silencing 
SAMMSON using antisense oligonucleotides reduced proliferation 
of all melanoma cultures independently of BRAF, NRAS and p53 
status and preserved sensitivity to BRAF inhibitors. (23) RNA pull 
down and mass spectroscopy identified a SAMMSON-associated 
protein, p32, known for its role in maintenance of mitochondrial 
membrane potential and oxidative phosphorylation. (25) Antisense 
nucleic acid-induced silencing of SAMMSON decreased 
mitochondrial membrane potential and triggered apoptosis, and 
the effect was rescued by reintroduction of p32. (23) Hence, 
SAMMSON silencing inhibits the survival of melanoma at least 
partly by disrupting p32-mediated mitochondrial functions. 
How does impaired mitochondrial function hinder cell 
proliferation? Collapsed mitochondrial membrane potential impairs 
the import of cytoplasmic proteins into mitochondria, which leads 
to toxic accumulation of mitochondrial precursors in the cytosol, 
stalling of the cell cycle and/or apoptosis. (26) The relevance of 
this mechanism was confirmed by exposure of human melanoma 
cells to inhibitors of translation, which abolished the lethal effect 
of SAMMSON silencing. (23) Importantly, intravenous treatment 
with SAMMSON-silencing antisense nucleic acids significantly 
suppressed the growth of human melanoma tumours injected into 
mice, (23) identifying SAMMSON as an attractive therapeutic 
target for the disruption of mitochondrial metabolism selectively in 
melanoma.
Competing endogenous RNA (ceRNA)
Specific miRNA molecules can be repressed experimentally using 
chemically modified antisense oligonucleotides or artificial miRNA 
sponges. The latter are synthetic RNA constructs harbouring 
multiple miRNA-binding elements (MREs). The competition 
for shared miRNAs between decoy MREs of the sponge and 
functional MREs of natural miRNA target transcripts titrates 
the amount of functional miRNA within the cell. Growing 
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understanding of human transcriptome led to postulating the 
existence of natural RNA sponges, whereby all (co-localised) 
RNA transcripts that contain MREs can communicate with and 
regulate each other by competing for shared miRNAs, thus acting 
as competing endogenous RNAs (ceRNAs) (27). In this way, 
protein-coding mRNAs may possess an additional non-coding 
function as ceRNAs. Though ceRNA research is still in infancy, 
the ceRNA role of lncRNAs, (28) mRNAs (29) and circular 
RNAs (30) has already been reported. For example, the non-coding 
PTENP1 pseudogene has been reported to regulate the levels of 
its cognate gene, the tumour suppressor PTEN, by competing for 
shared miRNAs. (31) PTENP1 pseudogene is frequently lost in 
human cancers, (31) which results for uncontrolled repression of 
PTEN protein by miRNAs. Intriguingly, comparison of cultured 
human transformed versus untransformed cells revealed that the 
former express mRNAs with shorter 3’ UTR regions. (32) While 
reducing their regulation by miRNA, this property also diminishes 
their ceRNA role. The functional consequence of this, if any, still 
remains to be elucidated. 
RNA trafficking and the controversy of ‘social’ RNA
Exosomes are plasma-membrane-derived vesicles that transfer 
proteins, mRNAs, miRNAs and other ncRNAs between cells. 
Returning to the study of sperm tRNA fragments (tRFs) in 
transgenerational inheritance: deep sequencing of sperm cells at 
different locations along the epididymis demonstrated that all sperm 
cells contained comparable amounts of tRNAs, yet the abundance 
of tRFs increased distally along the epididymis. (22) This suggests 
that tRFs are not the product of tRNA degradation within the 
sperm. Instead, deep sequencing showed the sperm tRFs to be 
derived from exosome-like vesicles released by epididymis termed 
epididymosomes, (22) suggesting that functional ncRNAs can 
participate in intracellular communication. 
miRNAs are trafficked around the body in high-density lipoprotein 
(HDL) particles. (33) The HDL-miRNA profile of healthy human 
subjects was found to be significantly different from patients with 
familial hypercholesterolemia and the two types of HDL induced 
different transcriptional profiles in cultured human hepatocytes as 
demonstrated by miRNA microarrays. (33) This demonstrated that 
HDL-transported miRNAs are functional, differ in disease states 
and can alter the transcriptome of target tissues.
Lastly and most controversially, the ‘social’ RNA hypothesis 
posits that the RNA world extends beyond the boundaries of an 
organism. (34) Within numerous limitations, RNA-containing 
complexes in the environment could influence gene expression 
profiles between animals of the same species as well as across 
species. Using miRNA microarray profiling of HDL-miRNA 
complexes, healthy human subjects in regular contact with different 
domesticated animals were demonstrated to possess different 
HDL-miRNA profiles that clustered based on the type of animal 
they were in contact with. (35) Furthermore, the differentially 
abundant miRNA species were shown to differentially regulate the 
pro-inflammatory NFκB pathway in cultured human macrophages, 
(35) contentiously suggesting that the type of animal one regularly 
contacts could influence one’s susceptibility to inflammation.
Conclusion
With comparable numbers of protein coding genes spanning the 
evolutionary tree from simple worms to humans, complexity 
is now believed to reside largely in the non-coding part of the 
genome previously dismissed as junk DNA or transcriptional noise. 
Unravelling the intricacies of this vast RNA underworld has already 
revealed numerous pathophysiological mechanisms, only a handful 
of which are presented here. To date, the role of some newly 
defined ncRNA classes, e.g. agotrons, (36) extra-coding RNAs 
(37) and enhancer RNAs (38) remains poorly characterised, which, 
together with the likely prospect of more ncRNA species still to 
be defined, heralds a profuse expansion of the newly (re)discovered 
layer of gene regulation and potential therapeutic applications.
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Figures
Figure 1: miRNA biogenesis and mode of action(39).
Reprinted by permission from Springer Nature: Nature Reviews 
Neuroscience (microRNAs at the synapse, Schratt G.), Copyright 
2009.
Figure 2: miR-125a stabilises iTreg cells and prevents their 
transition into pro-inflammatory TH17-like exTreg cells (adapted 
from(40)).
Reprinted by permission from Springer Nature: Nature Reviews 
Immunology (Interplay between the TH17 and TReg cell lineages: 
a (co-)evolutionary perspective, Weaver CT., and Hatton RD.), 
Copyright 2009.
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